Cardiac Valve Market Size, Share, Growth Analysis, By Types(Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves, and Others), By Position(Mitral Valve, Aortic Valve And Other Position), By End User(Cardiac Research Institute, Hospital & Clinics, Specialty Centers, And Others), By Treatment(Cardiac Wall Repair, and Cardiac Wall Replacement.), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2806 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 117 |Figures: 72

Cardiac Valve Market Insights

Global Cardiac Valve Market size was valued at USD 7.20 billion in 2022 and is poised to grow from USD 7.67 billion in 2023 to USD 12.69 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031).

Technological advancements are proving to be transformative in the management of heart failure and other cardiovascular diseases, reshaping the trajectory of treatment. As the prevalence of cardiac conditions continues to rise, there's a pronounced emphasis on pioneering sophisticated products. This escalating focus on innovation is poised to profoundly influence cardiovascular disease management in the predictable future. Moreover, the introduction of novel products by major industry players is poised to catalyze further growth in the market, propelling advancements and enhancing treatment methodologies.

Anticipated growth in the cardiac valve market between 2023 and 2030 is poised to be fueled by several significant drivers. Among these, the exponential increase in the global population affected by cardiovascular diseases emerges as a notable force propelling this expansion. The surging prevalence of diverse heart-related ailments, spanning from valvular disorders to coronary artery disease, has substantially elevated the demand for cardiac valve replacements. These implants serve as pivotal interventions, instrumental in reinstating optimal cardiac function and notably improving patient outcomes.

Market Snapshot - 2024-2031

Global Market Size

USD 7.20 billion

Largest Segment

Cardiac Wall Replacement

Fastest Growth

Growth Rate

6.50% CAGR

Global Cardiac Valve Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cardiac Valve Market Segmental Analysis

The global Cardiac Valve market can be categorized into the following segments. Based on Types, the market can be categorized into Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves And Others. Based on Treatment, the market can be categorized into Cardiac Wall Repair, Cardiac Wall Replacement. Based on Position, the market can be categorized into Mitral Valve, Aortic Valve And Other Position. Based on Treatment, the market can be categorized into Cardiac Valve Replacement, Cardiac Valve Repair And Other. Based on End User, the market can be categorized into Cardiac Research Institute, Hospital & Clinics, Specialty Centers And Others. Based on Region, the market can be categorized into North America, Europe, Asia Pacific, The Middle East and Africa.

Analysis by Treatment

The cardiac wall repair segment emerges as the foremost contributor to the market share, poised for substantial growth in the forecast period. This segment holds a pivotal role in catering to the requirements associated with rectifying or reconstructing the heart's compromised or irregular walls.

The cardiac wall replacement segment holds a crucial position within the cardiac valve market, focusing specifically on addressing issues related to damaged or structurally compromised heart walls. This segment encompasses a range of techniques, procedures, and devices tailored to repair, reconstruct, or reinforce the walls of the heart. It plays a vital role in addressing conditions such as aneurysms, myocardial infarction-related damage, congenital defects, and other structural abnormalities affecting the heart walls.

Analysis by Type

The tissue/bioprosthetic valves segment stands as the dominant market shareholder and is poised for substantial growth in the forthcoming forecast period. This segment denotes a specialized category of valves utilized in the replacement of impaired or ailing heart valves. Crafted from animal tissue, typically sourced from cows or pigs, these valves undergo meticulous chemical treatment and processing to render them suitable for implantation.

Transcatheter or percutaneous heart valves play a pivotal role in revolutionizing cardiac care within the cardiac valve market. These valves represent a minimally invasive alternative to traditional open-heart surgeries for valve replacement. Using catheter-based techniques, these specialized valves can be delivered and implanted within the heart, often through arteries or veins, without the need for open-chest procedures.

Global Cardiac Valve Market By Treatment

To get detailed analysis on other segments, Request For Free Sample Report

Cardiac Valve Market Regional Insights

In 2022, the North America Market asserted its dominance by securing a commanding market share of 45.50%. This notable achievement owes itself to a convergence of influential factors shaping the region's leadership position. The dominance is fueled by advanced medical expertise and the introduction of revolutionary cardiac valve solutions, both playing pivotal roles in this landscape. Furthermore, the implementation of stringent regulatory frameworks overseeing the production and upkeep of heart valve devices significantly contributes to the region's success.

The Asia-Pacific emerges as a promising frontier for market growth, propelled by several influential factors driving its expansion. A significant population base, increasing healthcare expenditures, and ongoing improvements in healthcare infrastructure contribute to the rapid development of this landscape. Particularly, nations like China, India, and Japan take the lead in advancing the market in the region, playing pivotal roles in its substantial expansion.

Global Cardiac Valve Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cardiac Valve Market Dynamics

Drivers

Rise in Burden Exerted by Valvular Heart Diseases

  • The expanding geriatric demographic, coupled with a shift towards sedentary lifestyles, stands as a significant driver behind the growing market. Advancements in heart valve technology and a heightened awareness of surgical interventions are further propelling this growth, especially with the increasing preference for minimally invasive procedures. For instance, the American College of Cardiology notes that approximately 5 million Americans are affected by heart valve disease annually.

Restraints

Stringent Government Regulations

  • The progress of the market encounters substantial obstacles due to rigorous government regulations governing the development, manufacturing, and usage of medical products, specifically cardiac valves. Compliance with these regulatory frameworks necessitates a multifaceted and labor-intensive procedure, encompassing thorough testing and detailed documentation to guarantee the safety and effectiveness of these medical devices.

Request Free Customization of this report to help us to meet your business objectives.

Cardiac Valve Market Competitive Landscape

The Global Cardiac Valve Market boasts a dynamic competitive landscape, featuring a blend of well-established brands, emerging players, and niche producers. Innovation stands as a pivotal competitive factor. Foremost brands heavily invest in research and development, introducing new flavors, packaging formats, and health-centric variations to meet evolving consumer preferences. Frequently, these brands set the trends within the industry, driving its direction and development.

Top Player’s Company Profiles

  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • LivaNova PLC
  • Abbott
  • CryoLife Inc
  • On-X Life Technologies Inc.
  • Colibri Heart Valve
  • JenaValve Technology Inc.
  • TTK HealthCare
  • LivaNova PLC
  • Abbott Laboratories
  • Colibri Heart Valve LLC
  • Artivion Inc.
  • Lepu Medical Technology Co Ltd.

Recent Developments

  • In December 2022, Abbott unveiled Navitor, its cutting-edge transcatheter aortic valve implantation (TAVI) system. This breakthrough signifies a monumental leap in cardiac care for individuals in India confronting severe aortic stenosis and classified as high or extremely risky for conventional surgical procedures. Navitor, a state-of-the-art minimally invasive device, represents a pivotal advancement, offering an innovative treatment avenue for patients encountering challenges with traditional surgical interventions.

Cardiac Valve Key Market Trends

  • The burgeoning market for Cardiac Valve devices is propelled by multiple factors, prominently including the escalating incidence of heart valve illnesses alongside the introduction of novel and enhanced cardiac valves securing regulatory endorsements. This growth trajectory is distinctly fueled by the increasing prevalence of heart valve diseases, a pivotal driving force within this sector. Notably, conditions like rheumatic heart disease, impacting 39 million individuals globally as per the World Heart Federation's 2022 data, significantly contribute to this trend. Rheumatic heart disease ensues when rheumatic fever chronically affects the heart valves, underscoring the imperative need for innovative cardiac valve solutions.

Cardiac Valve Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The rising prevalence of valvular heart disease, particularly aortic stenosis impacting the aortic valve, has fueled the growth of the market for Cardiac Valve devices and equipment. Aortic stenosis, a form of valvular heart ailment, causes stiffening of the aortic valve, impeding the regular flow of blood. To address this condition, the minimally invasive transcatheter aortic valve replacement (TAVR) procedure is employed.

Report Metric Details
Market size value in 2022 USD 7.20 billion
Market size value in 2031 USD 12.69 billion
Growth Rate 6.50%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Types
    • Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves, and Others
  • Position
    • Mitral Valve, Aortic Valve And Other Position
  • End User
    • Cardiac Research Institute, Hospital & Clinics, Specialty Centers, And Others
  • Treatment
    • Cardiac Wall Repair, and Cardiac Wall Replacement.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • LivaNova PLC
  • Abbott
  • CryoLife Inc
  • On-X Life Technologies Inc.
  • Colibri Heart Valve
  • JenaValve Technology Inc.
  • TTK HealthCare
  • LivaNova PLC
  • Abbott Laboratories
  • Colibri Heart Valve LLC
  • Artivion Inc.
  • Lepu Medical Technology Co Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cardiac Valve Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cardiac Valve Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cardiac Valve Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cardiac Valve Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cardiac Valve Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cardiac Valve Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Valve Market size was valued at USD 7.20 billion in 2022 and is poised to grow from USD 7.67 billion in 2023 to USD 12.69 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031).

The Cardiac Valve Market boasts a dynamic competitive landscape, featuring a blend of well-established brands, emerging players, and niche producers. Innovation stands as a pivotal competitive factor. Foremost brands heavily invest in research and development, introducing new flavors, packaging formats, and health-centric variations to meet evolving consumer preferences. Frequently, these brands set the trends within the industry, driving its direction and development. 'Medtronic', 'Edwards Lifesciences Corporation', 'Boston Scientific Corporation', 'LivaNova PLC', 'Abbott', 'CryoLife Inc', 'On-X Life Technologies Inc.', 'Colibri Heart Valve', 'JenaValve Technology Inc.', 'TTK HealthCare', 'LivaNova PLC', 'Abbott Laboratories', 'Colibri Heart Valve LLC', 'Artivion Inc.', 'Lepu Medical Technology Co Ltd.'

The expanding geriatric demographic, coupled with a shift towards sedentary lifestyles, stands as a significant driver behind the growing market. Advancements in heart valve technology and a heightened awareness of surgical interventions are further propelling this growth, especially with the increasing preference for minimally invasive procedures. For instance, the American College of Cardiology notes that approximately 5 million Americans are affected by heart valve disease annually.

The burgeoning market for Cardiac Valve devices is propelled by multiple factors, prominently including the escalating incidence of heart valve illnesses alongside the introduction of novel and enhanced cardiac valves securing regulatory endorsements. This growth trajectory is distinctly fueled by the increasing prevalence of heart valve diseases, a pivotal driving force within this sector. Notably, conditions like rheumatic heart disease, impacting 39 million individuals globally as per the World Heart Federation's 2022 data, significantly contribute to this trend. Rheumatic heart disease ensues when rheumatic fever chronically affects the heart valves, underscoring the imperative need for innovative cardiac valve solutions.

In 2022, the North America Market asserted its dominance by securing a commanding market share of 45.50%. This notable achievement owes itself to a convergence of influential factors shaping the region's leadership position. The dominance is fueled by advanced medical expertise and the introduction of revolutionary cardiac valve solutions, both playing pivotal roles in this landscape. Furthermore, the implementation of stringent regulatory frameworks overseeing the production and upkeep of heart valve devices significantly contributes to the region's success.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35A2806

$5,300
BUY NOW GET FREE SAMPLE